
- Volume 0 0
Noncardiac Chest Pain?Prevalence and Treatment
Noncardiac chest pain (NCCP), which isdefined as recurrent episodes of angina-likeretrosternal chest pain in patients without cardiacdisease, is associated with significant morbidityand economic burden. In the August2004 issue of Current Treatment Options inGastroenterology, Wai-Man Wong, MD, andRonnie Fass, MD, reviewed the prevalenceand treatment of NCCP. The esophagus is themost common source for NCCP, and, of theesophageal disorders, gastroesophageal refluxdisease (GERD)?which affects up to 60% ofpatients with NCCP?is the disorder that mostcommonly causes this condition.
Although many patients with NCCP reportheartburn and chest pain, some report onlychest pain. Treatments for NCCP include protonpump inhibitor therapy, which is the mosteffective medical treatment for GERD-relatedNCCP. Therapies used for non?GERD-relatedNCCP include pain modulators (such as tricyclicantidepressants, trazodone, and selectiveserotonin [5-hydroxytryptamine; 5-HT] reuptakeinhibitors) and, in a subset of patients,cognitive behavioral therapy. The authors concludedthat newer agents, such as theophyllineand selective 5-HT type 4 (5-HT4) receptor agonists,may supplement or replace current treatmentsfor non?GERD-related NCCP.
Articles in this issue
about 21 years ago
Rural Pharmacy Chain Chooses ScriptPro Automationabout 21 years ago
System Improves Productivity, Drug Verificationabout 21 years ago
COMPOUNDING HOTLINEabout 21 years ago
Cardinal Introduces PatientPAK 340Babout 21 years ago
Obesity Is an Addiction, Researchers Sayabout 21 years ago
Scientists Seek to Understand How Fat Causes Cancerabout 21 years ago
Government Plans Attack on Obesityabout 21 years ago
Gene Discovery May Unlock Key to Obesity Syndromeabout 21 years ago
Consuming Fruit, Not Fat, Staves Off Weight GainNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.